Overview
Ropes & Gray’s healthcare and life sciences industry group serves the legal and business needs of the world’s leading industry participants. Representing clients across all sub-sectors, our internationally-recognized team counsels pharma, biotech and medical device companies; digital health enterprises and technology companies expanding into the industry; major hospital systems, academic medical centers, and healthcare service providers; and hundreds of investors, including private equity, asset management, venture capital, and investment banking firms. Drawing on resources in our offices around the globe, which include EU and China regulatory specialists, we focus on developing cutting edge solutions to help clients meet their business goals.
Smart. Strategic. Solution-oriented. Client-friendly.
Clients trust Ropes & Gray’s healthcare and life sciences team across every aspect of their businesses:
- Mergers & Acquisitions
- Licensing, Collaborations & Joint Ventures
- Capital Markets
- Healthcare & FDA Regulatory and Compliance
- Private Equity
- Venture Capital & Emerging Companies
- Privacy & Cybersecurity
- Antitrust
- Intellectual Property
- Securities Litigation & Enforcement
- Government Enforcement
- False Claims Act
- Tax, Benefits & Executive Compensation
- Business Restructuring
- Real Estate
Global reach. Internationally recognized team.
Thought Leadership
- Reality is Tricky Business in Effective Implementation of the EU Medical Devices Regulation
- CMS Publishes Calendar Year 2023 Hospital Outpatient Payment Final Rule and Addresses 340B Drug Payments, Organ Acquisition Costs, Pandemic-Related Payment Changes, Rural Hospitals
- Enhancing Cancer Care: New CMMI Model Invites Physician Practices, Payers to Reconsider Traditional Reimbursement for Oncology Services
- New York Introduces Health Care and Mental Hygiene Worker Bonus (HWB) Program
- Congress Paves the Way for Drug Pricing Reforms with Passage of the Inflation Reduction Act of 2022
- In Law360, Health Care Attorneys Examine Ways That State Oversight May Impact Nationwide Health Transactions
- In Bloomberg Law, Margaux Hall Discusses Drugmaker Data Protection in Medicare Price Negotiation Guidance
- In Bloomberg Law, Attorneys Analyze Transactional Implications of Inflation Reduction Act’s Drug Pricing Provisions
- Ropes & Gray Advises Provention Bio in $2.9 Billion Sale to Sanofi
- Ropes & Gray Advises Sarepta Therapeutics in $313.5 Million Convertible Senior Notes Exchange
- Mark Barnes Presents at Virtual Asia Pacific Open Forum in Singapore
- Leslie Thornton to Present American Health Law Association Webinar on Life Sciences 2022 Roundup and 2023 Outlook
- David McIntosh and Margaux Hall Host Webinar on the Inflation Reduction Act’s Impact on Deal Terms
- Margaux Hall Presents at Medicaid & Government Pricing Congress
- David Peloquin Presents at U.S. Africa Leaders Summit Science Collaboration
- Ropes & Gray Named The American Lawyer’s “Law Firm of the Year” and Honored for Life Sciences and Health Care
- Torrey McClary Named a Top Health Care Lawyer by Daily Journal
- Ropes & Gray Ranks Highly in 2022 LMG Life Sciences Guide
- Ropes & Gray Named “Law Firm of the Year—Pharmaceutical & Biotechnology” at The Deal Awards
- Ropes & Gray Honored With Five 2022 LMG Life Sciences Americas Awards
